CRTD receives 1.56 Mill. Euro BMBF-funding for retinal disease research

The research groups lead by Prof. Dr. Elly Tanaka, Prof. Dr. Marius Ader and Dr. Mike Karl at the DFG-Research Center for Regenerative Therapies Dresden (CRTD) – Cluster of Excellence at TU Dresden, have received funding in the BMBF program “Validation of the technological and societal innovation potential of scientific research – VIP+” with their CLEANSIGHT research team. The research project will focus on validating a retinal cell–based screening platform for fast and efficient identification of small molecules for the treatment of retinal degenerative diseases. (Mehr in: Pressemitteilungen – idw – Informationsdienst Wissenschaft)